dc.creator | Perivoliotis K., Sioka E., Tatsioni A., Stefanidis I., Zintzaras E., Zacharoulis D. | en |
dc.date.accessioned | 2023-01-31T09:47:29Z | |
dc.date.available | 2023-01-31T09:47:29Z | |
dc.date.issued | 2017 | |
dc.identifier | 10.1155/2017/7526494 | |
dc.identifier.issn | 20901402 | |
dc.identifier.uri | http://hdl.handle.net/11615/78073 | |
dc.description.abstract | Background. A meta-analysis was conducted in order to provide an up-to-date comparison of pancreatogastrostomy (PG) and pancreatojejunostomy (PJ), after pancreatoduodenectomy (PD), in terms of clinically significant postoperative pancreatic fistula (POPF) and other postoperative complications. Methods. This meta-analysis was conducted according to the PRISMA guidelines and the Cochrane Handbook for Systematic Reviews of Interventions. A systematic literature search in MEDLINE and Cochrane Central Register of Controlled Clinical Trials was performed. Fixed Effects or Random Effects model was used, based on the Cochran Q test. Results. In total, 10 studies (1629 patients) were included. There was no statistical significance between PG and PJ regarding the rate of clinically significant POPF (OR: 0.70, 95%CI: 0.46-1.06). PG was associated with a higher rate of postpancreatoduodenectomy haemorrhage (PPH) (OR: 1.52, 95%CI: 1.08-2.14). There was no difference between the two techniques in terms of clinically significant PPH (OR: 1.35, 95%CI: 0.95-1.93) and clinically significant postoperative delayed gastric emptying (DGE) (OR: 0.98, 95%CI: 0.59-1.63). Discussion. There is no difference between the two anastomotic techniques regarding the rate of clinically significant POPF. Given several limitations, more large scale high quality RCTs are required. © 2017 Konstantinos Perivoliotis et al. | en |
dc.language.iso | en | en |
dc.source | International Journal of Surgical Oncology | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027227839&doi=10.1155%2f2017%2f7526494&partnerID=40&md5=ef21277f31529652ef66be495de06e07 | |
dc.subject | ampulla of Vater | en |
dc.subject | anastomosis | en |
dc.subject | comparative study | en |
dc.subject | digestive system tumor | en |
dc.subject | gastrostomy | en |
dc.subject | human | en |
dc.subject | meta analysis | en |
dc.subject | pancreas | en |
dc.subject | pancreas fistula | en |
dc.subject | pancreas tumor | en |
dc.subject | pancreaticoduodenectomy | en |
dc.subject | pancreaticojejunostomy | en |
dc.subject | randomized controlled trial (topic) | en |
dc.subject | stomach | en |
dc.subject | Ampulla of Vater | en |
dc.subject | Anastomosis, Surgical | en |
dc.subject | Digestive System Neoplasms | en |
dc.subject | Gastrostomy | en |
dc.subject | Humans | en |
dc.subject | Pancreas | en |
dc.subject | Pancreatic Fistula | en |
dc.subject | Pancreatic Neoplasms | en |
dc.subject | Pancreaticoduodenectomy | en |
dc.subject | Pancreaticojejunostomy | en |
dc.subject | Randomized Controlled Trials as Topic | en |
dc.subject | Stomach | en |
dc.subject | Hindawi Limited | en |
dc.title | Pancreatogastrostomy versus Pancreatojejunostomy: An Up-to-Date Meta-Analysis of RCTs | en |
dc.type | other | en |